BPC-157 Targets specific areas of damage including muscles, tendons, ligaments, and the gut
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
We always work hard to create a personalized treatment plan for your needs
Non-Returnable Related products COBAL 1000, CYANOCOBALAMIN INJ, USP, MDV 1000MCG/ML 30ML Login to see prices & order HEPARIN L/F SYRINGE, 100UNITS/ ML, 5ML, 30 BX NDC 08290306424 NON-RETURNABLE Login to see prices & order DEPO-MEDROL 80MG/ML, 5ML, (METHYLPREDNISOLONE ACETATE INJ SUSPENSION, USP), MDV, NDC 00009030602 NON-RETURNABLE Login to see prices & order LIDOCAINE 1% WITH EPI, 30ML LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION 1:100,000, USP, MDV, 1% 10MG/ML (300MG/30ML), 30ML NDC 00409317802 NON-RETURNABLE Login to see prices & order Call 800 69 MERIT for pharmaceuticals, medical devices and related professional healthcare products